Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Petitou

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Carbohydrate Research|July 15, 1987
Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIM Ragazzi, D R Ferro, B Perly, et al.
European Journal of Clinical Pharmacology|June 5, 2016
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of actionPierre Gueret, S Combe, C Krezel, et al.
Thrombosis and Haemostasis|April 8, 1988
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does notY Cadroy, F Dol, C Caranobe, et al.
The Biochemical Journal|September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studiesB Casu, P Oreste, G Torri, et al.
Thrombosis and Haemostasis|March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbitS Saivin, F Dol, C Caranobe, et al.
Thrombosis and Haemostasis|June 27, 2002
Pharmacokinetics of new synthetic heparin mimeticsJ P Hérault, A Bernat, F Roye, et al.
Nature|April 14, 1999
Synthesis of thrombin-inhibiting heparin mimetics without side effectsM Petitou, J P Hérault, A Bernat, et al.
Journal of Thrombosis and Haemostasis : JTH|July 24, 2008
Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapyP Savi, J P Herault, P Duchaussoy, et al.
British Journal of Haematology|April 1, 1992
Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbitsS Saivin, C Caranobe, M Petitou, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Carbohydrate Research|July 15, 1987
Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIM Ragazzi, D R Ferro, B Perly, et al.
European Journal of Clinical Pharmacology|June 5, 2016
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of actionPierre Gueret, S Combe, C Krezel, et al.
Thrombosis and Haemostasis|April 8, 1988
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does notY Cadroy, F Dol, C Caranobe, et al.
The Biochemical Journal|September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studiesB Casu, P Oreste, G Torri, et al.
Thrombosis and Haemostasis|March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbitS Saivin, F Dol, C Caranobe, et al.
Thrombosis and Haemostasis|June 27, 2002
Pharmacokinetics of new synthetic heparin mimeticsJ P Hérault, A Bernat, F Roye, et al.
Nature|April 14, 1999
Synthesis of thrombin-inhibiting heparin mimetics without side effectsM Petitou, J P Hérault, A Bernat, et al.
Journal of Thrombosis and Haemostasis : JTH|July 24, 2008
Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapyP Savi, J P Herault, P Duchaussoy, et al.
British Journal of Haematology|April 1, 1992
Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbitsS Saivin, C Caranobe, M Petitou, et al.
Pageof 12